Whittier Trust’s Allergan plc AGN.PRA Stock Holding History

Whittier Trust’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-49	Closed	-$42K	–	1378
2017 Q1	$42K	Buy	+49	New	+$40.6K	﹤0.01%	743

Other funds holding AGN.PRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

Whittier Trust's AGN.PRA Position: Q2 2017 in Review

Whittier Trust sold out of Allergan plc (AGN.PRA) in Q2 2017, closing a stake of 49 shares — an estimated $42K sold.

Whittier Trust first reported a position in AGN.PRA in Q1 2017 and held it in 1 quarter. The position peaked at $42K in Q1 2017. 109 funds tracked by Wall St. Rank hold AGN.PRA as of Q2 2017.

Whittier Trust reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
Whittier Trust sold 49 Allergan plc shares in Q2 2017, an estimated $42K.
Whittier Trust first reported a position in Allergan plc in Q1 2017 and held it in 1 quarter.
Whittier Trust's Allergan plc position peaked at $42K in Q1 2017.
109 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Whittier Trust's 13F filing for Q2 2017, filed 20 Jul 2017.